icon-folder.gif   Conference Reports for NATAP  
 
  Glasgow HIV
28 - 31 October 2018
Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
High Prevalence of Previously Undocumented Baseline M184V/I Does Not Affect Virologic Outcome in Virologically-Suppressed Patients Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from a Boosted Protease Inhibitor-based Regimen
 
 
  Reported by Jules Levin
HIV Glasgow, 28-31 October 2018, Glasgow, UK
 
Kristen Andreatta, Richard Haubrich, Madeleine Willkom, Ross Martin, Silvia Chang, Rima Acosta, Ya-Pei Liu, Hiba Graham, Erin Quirk, and Kirsten L. White Gilead Sciences, Inc., Foster City, CA 94404 USA

1108181

1108182

1108183

1108184

1108185

1108186

1108187

1108188

1108189